longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CARSGEN-B

02171

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -73.73, below the reasonable range, cheaper than 90.34% of the time in the past 5 years, and the industry ranks 72/78, the industry Median -5.53.

-73.73xP/E
HK$12.74Stock price
HK$-0.17Earnings per share
-73.73xP/E
Stock priceHK$12.74Earnings per shareHK$-0.17

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.01x
Typical range
-15.54x–-3.63x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0166332498664

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-79.17x83.10%HK$88.15B
09688HKZAI LAB
-14.62x505.86%HK$21.57B
07666HKMETIS TECHBIO-P
-44.05x96.70%HK$17.93B
01877HKJUNSHI BIO
-38.29x84.85%HK$17.72B
09606HKDUALITYBIO-B
-10.20x82.04%HK$16.89B
09887HKLEADS BIOLABS-B
-39.80x9.00%HK$12.23B
06855HKASCENTAGE
-7.08x18.21%HK$11.98B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
02595HKGENFLEET-B
-6.53x78.96%HK$9.90B
01952HKEVEREST MED
-154.68x324.61%HK$9.60B
02616HKCSTONE PHARMA-B
-19.77x1.96%HK$9.54B
01672HKASCLETIS-B
-13.90x78.59%HK$9.47B
02493HKMABWELL-B
-8.51x--HK$9.21B
06938HKRIBOLIFE-B
-46.20x29.88%HK$9.02B
09966HKALPHAMAB-B
-38.33x--HK$7.77B
02171HKCARSGEN-B
-73.73x51.12%HK$7.57B
01779HKLONGBIO-B
-29.47x--HK$7.33B
02335HKMICOT PHARMA-B
-16.46x37.50%HK$6.91B
06872HKTENNOR THERAP-B
-40.78x--HK$6.54B
02256HKABBISKO-B
-11.62x300.95%HK$6.24B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.